CLOROX CO /DE/
Financial highlights
| Metric | FY 06/30/25 | FY 06/30/24 | FY 06/30/23 | FY 06/30/22 | FY 06/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.1B | $7.1B | $7.4B | $7.1B | $7.3B |
| Cost of revenue | $3.9B | $4.0B | $4.5B | $4.6B | $4.1B |
| Gross profit | $3.2B | $3.0B | $2.9B | $2.5B | $3.2B |
| Selling, general & administrative | $1.1B | $1.2B | $1.2B | $954.0M | $1.0B |
| Research and development | $121.0M | $126.0M | $138.0M | $132.0M | $149.0M |
| Interest expense | $88.0M | $90.0M | $90.0M | $106.0M | $99.0M |
| Pretax income | $1.1B | $398.0M | $238.0M | $607.0M | $900.0M |
| Income tax expense | $254.0M | $106.0M | $77.0M | $136.0M | $181.0M |
| Net income | $810.0M | $280.0M | $149.0M | $462.0M | $710.0M |
| Balance Sheet | |||||
| Cash and equivalents | $167.0M | $202.0M | $367.0M | $183.0M | $319.0M |
| Current assets | $1.6B | $1.6B | $1.8B | $1.7B | $1.8B |
| Total assets | $5.6B | $5.8B | $5.9B | $6.2B | $6.3B |
| Current liabilities | $1.9B | $1.6B | $1.9B | $1.8B | $2.1B |
| Total liabilities | $5.1B | $5.3B | $5.6B | $5.4B | $5.7B |
| Stockholders' equity | $321.0M | $328.0M | $220.0M | $556.0M | $411.0M |
| Cash Flow Statement | |||||
| Cash from operations | $981.0M | $695.0M | $1.2B | $786.0M | $1.3B |
| Depreciation and amortization | $219.0M | $235.0M | $236.0M | $224.0M | $211.0M |
| Stock-based compensation | $81.0M | $74.0M | $73.0M | $52.0M | $50.0M |
| Capital expenditure | $220.0M | $212.0M | $228.0M | $251.0M | $331.0M |
| Free cash flow | $761.0M | $483.0M | $930.0M | $535.0M | $945.0M |
| Dividends paid | $602.0M | $595.0M | $583.0M | $571.0M | $558.0M |
| Share repurchases | $332.0M | $0 | $0 | $25.0M | $905.0M |
| Impairments | $0 | $0 | $445.0M | $0 | $329.0M |
Shares outstanding 120.9M · Free float 89.1%
Annual filing data through FY ended June 30, 2025; float as of July 8, 2026.
Recent filings
- June 17, 2026 8-K
- May 28, 2026 8-K
- May 11, 2026 8-K
- April 30, 2026 10-Q
- April 30, 2026 8-K
- April 1, 2026 8-K
- March 10, 2026 8-K
- February 3, 2026 10-Q